Post-radiation xerostomia therapy with allogeneic mesenchymal stromal stem cells in patients with head and neck cancer: study protocol for phase I clinical trial

DISCUSSION: The use of allogeneic MSCs from umbilical cord tissue represents an innovative approach for the treatment of xerostomia after radiation. Due to the noninvasive collection procedure, flexibility of cryobanking, and biological advantages, xerostomia therapy using allogeneic MSCs from umbilical cord tissue may have an advantage over other similar therapies.PMID:38038413 | DOI:10.2478/raon-2023-0052

Source: Cancer Control - December 1, 2023 Category: Cancer & Oncology Authors: Primoz Strojan Gaber Plavc Marko Kokalj Goran Mitrovic Olga Blatnik Luka Lezaic Aljaz Socan Aljosa Bavec Natasa Tesic Katrina Hartman Urban Svajger Source Type: research